BioPharma Today

Latest News From "The Pink Sheet" DAILY - FDA Approves Teva's Leukemia Drug Synribo

With Singulair Gone, It's Test Time For Merck's Post-LOE Strategy With Singulair's loss of exclusivity on Aug. 3, Merck's bets on growth of its existing franchises and late-stage pipeline have come under scrutiny. Next up: Tredaptive Phase III data in early 2013.

Editor's Picks from the World Press

Business & Finance

Gliknik raises $4.9M to advance autoimmune drug candidate
MedCityNews.com Oct. 8, 2012

Editor's Picks from the World Press

Business & Finance

BioSante and ANI merge in all-stock agreement worth $95M
American City Business Journals Oct. 4, 2012

Editor's Picks from the World Press

Business & Finance

Ablynx and Merck sign nanobody deal worth as much as $590M
PharmaTimes (U.K.) Oct. 2, 2012

Editor's Picks From The World Press

Business & Finance

Prana raises $6.2M for neurodegenerative disease drug candidate
ProactiveInvestors.co.au (Australia) Oct. 2, 2012

Astellas licenses anti-inflammatory candidate to Janssen
Pharmaceutical Business Review Online Oct. 2, 2012

Sanofi will purchase Genfar to expand in South America
Reuters Oct. 2, 2012

Government & Legal News

FDA grants orphan designation to Cleveland BioLabs cancer drug
American City Business Journals Oct. 2, 2012

FDA gives orphan-drug status to Cell Therapeutics brain cancer drug
American City Business Journals Oct. 2, 2012

Lundbeck and Takeda submit antidepressant for FDA approval
Drug Store News Oct. 2, 2012

NIH division grants GeoVax $1.9M to develop HIV vaccine
Pharmaceutical Business Review Online Oct. 2, 2012

Judge orders Abbott to pay $700M in Depakote-tied fines and costs
Reuters Oct. 2, 2012

Pipeline/R&D News

Sanofi drug works against Gaucher disease in late-stage study
Reuters Oct. 2, 2012

Heart drug Mexitil eases nondystrophic myotonias in trial
MedPage Today Oct. 2, 2012

Study shows efficacy of Janssen's Stelara for psoriasis
Pharmaceutical Business Review Online Oct. 2, 2012

Genentech-Immunogen breast cancer drug prolongs survival in trial
MedPage Today Oct. 1, 2012, Xconomy Oct. 1, 2012

Editor's Picks from the World Press

Business & Finance

ProStrakan buys GTx's breast cancer drug Fareston for $21.7M
American City Business Journals Oct. 1, 2012

Editor's Picks from the World Press

Business & Finance

Teva moves toward branded drugs by buying NeuroSearch drug
Bloomberg Businessweek Sep. 27, 2012

Editor's Picks From The World Press

Business & Finance

NuPathe raises $28M to commercialize migraine patch Zelrix
MedCityNews.com Sep. 26, 2012

Merck backs out of deal with Cardiome tied to heart drug
Reuters Sep. 26, 2012

Government & Legal News

Astellas unit submits organ-transplant drug for FDA approval
Drug Store News Sep. 26, 2012

Bristol and Pfizer resubmit anticlotting drug Eliquis for FDA OK
The Boston Globe Sep. 26, 2012

GSK and Theravance seek FDA approval of lung drug Breo
CNBC Sep. 26, 2012

HHS grants FDA authority to oversee clinical-trial data
Pharmalot.com Sep. 25, 2012

User-fee collection for generics can begin Monday
Modern Healthcare (subscription required) Sep. 25, 2012

Pipeline/R&D News

Protein Potential will develop malaria vaccine using NIH grants
Genetic Engineering & Biotechnology News Sep. 26, 2012

Brilinta cuts cardiovascular death better than Plavix in CABG patients
MedPage Today Sep. 26, 2012

Generic diabetes therapy might treat cancer
Bloomberg Sep. 26, 2012

Corticosteroids is unlikely to raise bleeding risk after tonsillectomy
HealthDay News Sep. 26, 2012

PsiOxus initiates human trial of experimental cancer vaccine
Bloomberg Businessweek Sep. 26, 2012

Editor's Picks From The World Press

Business & Finance

NextBio and cancer institute partner on multiple myeloma drugs
GenomeWeb Daily News (free registration) Sep. 24, 2012

Reckitt plans U.S. pullout of Suboxone tablet in favor of film
Reuters Sep. 25, 2012

Novo allots $100M for R&D expansion in China
PharmaTimes (U.K.) Sep. 25, 2012

Government & Legal News

FDA expedites review of Sucampo-Takeda constipation drug Amitiza
Pharmaceutical Business Review Online Sep. 26, 2012, CNBC Sep. 25, 2012

Hemispherx's fatigue drug Ampligen is up for FDA review in December
CNBC Sep. 24, 2012

Antibiotic development is focus of FDA task force
Drug Store News Sep. 24, 2012

Alnylam can file patent suit against Tekmira, U.S. court says
Reuters Sep. 25, 2012

Depomed seeks Gralise market exclusivity in suit against FDA
Reuters Sep. 25, 2012

Pipeline/R&D News

Versartis drug shows promise against growth-hormone deficiency
Pharmaceutical Business Review Online Sep. 25, 2012

Study of Merck's lonafarnib offers insight into cardiovascular aging
The Wall Street Journal Sep. 24, 2012

Bleeding risk offsets benefit of newer anticoagulants in study
MedPage Today Sep. 24, 2012

Cellceutix kicks off first human trial of cancer drug Kevetrin
Mass High Tech (Boston) Sep. 24, 2012

Editor's Picks from the World Press

Business & Finance

Valeant buys QLT's eye drug Visudyne for $112.5M
Drug Store News Sep. 24, 2012